The Intersection of DNA Damage Response and Ferroptosis-A Rationale for Combination Therapeutics

被引:27
|
作者
Chen, Po-Han [1 ,2 ,3 ]
Tseng, Watson Hua-Sheng [1 ,2 ,4 ]
Chi, Jen-Tsan [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
[2] Duke Univ, Sch Med, Ctr Genom & Computat Biol, Durham, NC 27710 USA
[3] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
来源
BIOLOGY-BASEL | 2020年 / 9卷 / 08期
关键词
ferroptosis; DNA damage; ATM; ATR; p53; MDM2; MDMX; CELL-DEATH; ATM ACTIVATION; P53; ACTIVATION; ATAXIA-TELANGIECTASIA; ONCOPROTEIN MDM2; HIPPO PATHWAY; PROTEIN; PHOSPHORYLATION; PROMOTES; METABOLISM;
D O I
10.3390/biology9080187
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis are gaining recognition, much remains unknown about its interaction with other biological processes and pathways. Recently, several studies have identified intricate and complicated interplay between ferroptosis, ionizing radiation (IR), ATM (ataxia-telangiectasia mutated)/ATR (ATM and Rad3-related), and tumor suppressor p53, which signifies the participation of the DNA damage response (DDR) in iron-related cell death. DDR is an evolutionarily conserved response triggered by various DNA insults to attenuate proliferation, enable DNA repairs, and dispose of cells with damaged DNA to maintain genome integrity. Deficiency in proper DDR in many genetic disorders or tumors also highlights the importance of this pathway. In this review, we will focus on the biological crosstalk between DDR and ferroptosis, which is mediated mostly via noncanonical mechanisms. For clinical applications, we also discuss the potential of combining ionizing radiation and ferroptosis-inducers for synergistic effects. At last, various ATM/ATR inhibitors under clinical development may protect ferroptosis and treat many ferroptosis-related diseases to prevent cell death, delay disease progression, and improve clinical outcomes.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [21] Advance on combination therapy strategies based on biomedical nanotechnology induced ferroptosis for cancer therapeutics
    Chen, Shuang
    Shi, Jialin
    Yu, Dongzhi
    Dong, Siyuan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 176
  • [22] Synergistic effect of MSLN-TTC in combination with DNA damage response inhibitors
    Wickstroem, Katrine
    Hagemann, Urs B.
    Wengner, Antje M.
    Kristian, Alexander
    Ellingsen, Christine
    Siemeister, Gerhard
    Bjerke, Roger M.
    Karlsson, Jenny
    Ryan, Olav B.
    Linden, Lars
    Kreft, Bertolt
    Mumberg, Dominik
    Wild, Hanno
    Ziegelbauer, Karl
    Cuthbertson, Alan
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Model guided understanding of synergistic combination therapies in the DNA damage response pathway
    Raue, Andreas
    Alkan, Ozan
    Drummond, Daryl
    Schoeberl, Birgit
    CANCER RESEARCH, 2015, 75 (22)
  • [24] Telomerase therapeutics: Telomeres recognized as a DNA damage signal
    Shay, JW
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3521 - 3525
  • [25] Engineering a DNA damage response without DNA damage
    Yeung, ManTek
    Durocher, Daniel
    GENOME BIOLOGY, 2008, 9 (07)
  • [26] Engineering a DNA damage response without DNA damage
    ManTek Yeung
    Daniel Durocher
    Genome Biology, 9
  • [27] DNA Damage Response
    Giglia-Mari, Giuseppina
    Zotter, Angelika
    Vermeulen, Wim
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2011, 3 (01): : 1 - 19
  • [28] The DNA damage response
    Elledge, SJ
    Zou, L
    Cortez, D
    FASEB JOURNAL, 2002, 16 (05): : A740 - A740
  • [29] DNA Damage Response
    Oksenych, Valentyn
    Kainov, Denis E.
    BIOMOLECULES, 2021, 11 (01)
  • [30] DNA damage response
    Elledge, SJ
    SCIENTIST, 2003, 17 (22): : 11 - 11